| Progression-free survival | Overall survival | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | ||||||||
Variables | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-Value | HR (95% CI) | p-value | ||||
Age (years) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
≥60 vs. <60 | 1.28 | (0.92–1.76) | 0.14 |  |  |  | 1.21 | (0.82–1.78) | 0.34 |  |  |  |
FIGO stage | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
I vs. II, III, IV | 0.16 | (0.07–0.30) | <0.01 | 0.28 | (0.12–0.61) | <0.01 | 0.05 | (0.01–0.17) | <0.01 | 0.10 | (0.01–0.34) | <0.01 |
Residual tumor at PDS | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Yes vs. No | 2.26 | (1.57–3.33) | <0.01 | 1.17 | (0.78–1.79) | 0.46 | 2.61 | (1.67–4.24) | <0.01 | 1.15 | (0.73–1.91) | 0.56 |
Histological subtype | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
MC with expansile invasion vs. HGSC | 0.08 | (0.01–0.24) | <0.01 | 0.17 | (0.03–0.58) | <0.01 | 0.06 | (0.003–0.25) | <0.01 | 0.18 | (0.01–0.86) | 0.03 |